Santarus and VeroScience Announce Publication of Positive Data From Pivotal …
Santarus and VeroScience Announce Publication of Positive Data from Pivotal …
Filed under: drug treatment programs in san diego
SAN DIEGO & TIVERTON, R.I.–(BUSINESS WIRE)–Jan 23, 2013 – Santarus, Inc. (NASDAQ: SNTS) and VeroScience, LLC today announced publication of positive data from a double-blind, placebo-controlled, multi-center pivotal study with CYCLOSET® …. R.I …
Read more on PharmaLive (press release) (subscription)
Trius Therapeutics, Inc. Announces Exercise of Underwriters' Option to …
Filed under: drug treatment programs in san diego
SAN DIEGO, Jan. 23, 2013 (GLOBE NEWSWIRE) — Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced that the underwriters of its previously announced public offering of common stock that priced on January 17, 2013, have exercised their option to …
Read more on GlobeNewswire (press release)
MAPP Bought Out, TELK Rises, TSOI, AMPE Begin Anew, EDAP On High, CLSN …
Filed under: drug treatment programs in san diego
MAP Pharma's LEVADEX, an orally inhaled drug for the potential acute treatment of migraine in adults, is currently under FDA review with a decision expected on April 15, 2013. Celgene International SÃ … The company will also move its corporate …
Read more on NASDAQ
Alzheimer's: NIH Research Grant Provides Funding For Non-Traditional …
Filed under: drug treatment programs in san diego
The A4 (Anti-amyloid treatment in asymptomatic Alzheimer's disease) secondary prevention trial will test an amyloid-clearing drug in the pre-symptomatic stage of the disease, in 1,000 symptom-free older volunteers who have had positron emission …
Read more on Guardian Express